Axsome Therapeutics Presents New Data and Post-Hoc Analyses of Auvelity® in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2023 Annual MeetingGlobeNewsWire • 12/11/23
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders TodayGlobeNewsWire • 12/07/23
AXSM FINAL DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors to Secure Counsel Before Important December 7 Deadline in Securities Class Action - AXSMPRNewsWire • 11/26/23
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7GlobeNewsWire • 11/22/23
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare ConferenceGlobeNewsWire • 11/21/23
ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors to Secure Counsel Before Important December 7 Deadline in Securities Class Action - AXSMPRNewsWire • 11/20/23
Rosen Law Firm Announces the Reopening of the Lead Plaintiff Appointment Process in a Class Action Against Axsome Therapeutics, Inc. and Certain Officers – AXSMBusiness Wire • 11/17/23
3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest RatesThe Motley Fool • 11/09/23
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 11/06/23
Axsome Therapeutics and the Global Alzheimer's Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer's Disease Awareness Month 2023GlobeNewsWire • 11/02/23
Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer's Disease Agitation at the Clinical Trials on Alzheimer's Disease (CTAD) 2023 ConferenceGlobeNewsWire • 10/24/23
Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6GlobeNewsWire • 10/10/23
Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness WeekGlobeNewsWire • 10/02/23
Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy DayGlobeNewsWire • 09/21/23